AETHLON MEDICAL INC (AEMD) Earnings History & Surprises

NASDAQ:AEMDUS00808Y6041

Current stock price

2.17 USD
-0.05 (-2.25%)
Last:

AEMD Earnings overview

Past quarterly earnings results for AETHLON MEDICAL INC (AEMD), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
Jun 24, 2026
Period
Q4 / 2026
EPS Estimate
-$2.06
Revenue Estimate

Last Reported

Most Recent
Release Date
Feb 12, 2026
Period
Q3 / 2026
EPS Reported
-$2.45
EPS Surprise
0.75%
Revenue Surprise
%

Beat Rate

Last 8 Quarters
25%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q3 2026 -2.45 -2.47 0.75% 76.44% - -
Q2 2026 -3.74 -3.74 -0.09% 76.63% - -
Q1 2026 -8.50 -8.77 3.10% 68.75% - -
Q4 2025 -79.70 -10.30 -673.64% -9.48% - -
Q3 2025 -10.40 -17.41 40.26% 90.51% - -
Q2 2025 -16.00 -15.91 -0.55% 83.61% - -
Q1 2025 -27.20 -25.70 -5.82% 75.71% - -
Q4 2024 -72.80 -100.37 27.47% 9.00% - -100.00%
Q3 2024 -109.60 -100.37 -9.20% -14.17% - -
Q2 2024 -97.60 -114.24 14.57% 32.22% - -
Q1 2024 -112.00 -106.08 -5.58% 26.32% - -
Q4 2023 -80.00 -106.08 24.59% 61.54% 574.25K - 5,642.50%
Q3 2023 -96.00 -65.28 -47.06% 25.00% 3.235M -100.00% -100.00%
Q2 2023 -144.00 -175.44 17.92% -38.46% 70.89K -100.00% -100.00%
Q1 2023 -152.00 -179.52 15.33% -18.75% 70.89K -100.00% -100.00%
Q4 2022 -208.00 -114.24 -82.07% -73.33% 10K 735.42K -98.64% -66.67%
Q3 2022 -128.00 -106.08 -20.66% 20.00% 20K 261.12K -92.34% -96.77%
Q2 2022 -104.00 -122.40 15.03% 13.33% 130K 192.78K -32.57% -
Q1 2022 -128.00 -106.08 -20.66% - 130K 204K -36.27% -
Q4 2021 -120.00 -160.48 25.23% 31.19% 30K 380.797K -92.12% -85.71%
Q3 2021 -160.00 -134.64 -18.84% 33.33% 620K 102K 507.84% 51.22%
Q2 2021 -120.00 -97.92 -22.55% 88.37% - -
Q1 2021 - - - -100.00%
Q4 2020 -174.40 -130.56 -33.58% - 210K 306K -31.37% -
Q3 2020 -240.00 -840.48 71.44% - 410K 191.76K 113.81% -
Q2 2020 -1,032.00 -897.60 -14.97% - 191.76K -100.00% -
Q1 2020 -1,080.00 -979.20 -10.29% - 30K - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

AEMD EPS Q2Q GrowthAEMD EPS Q2Q GrowthEPS Q2Q Growth Q2/21 Q4/21 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q1/26 Q3/26 Q1/27 Q3/27 0 50 -50

Revenue Historical Q2Q growth and Acceleration

AEMD Revenue Q2Q GrowthAEMD Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q3/21 Q4/21 Q3/22 Q4/22 Q1/23 Q2/23 Q3/23 Q4/23 Q4/24 0 1K 2K 3K 4K 5K

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
2
Average EPS beat (4)
-167.47%
Max EPS beat (4)
3.10%
Min EPS beat (4)
-673.64%

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

In the last 4 quarters, AEMD has beaten EPS estimates in 2 out of 4 releases
In the last 4 quarters, AEMD reported -167.5% below the EPS estimates on average.

AETHLON MEDICAL INC / AEMD Earnings FAQ

Can you provide the last earnings date for AETHLON MEDICAL INC?

AETHLON MEDICAL INC (AEMD) last reported earnings on 2/12/2026.

Can you provide information on whether AETHLON MEDICAL INC beat earnings estimates in the last quarter?

AETHLON MEDICAL INC (AEMD) beat EPS estimates and missed revenue estimates in the most recent quarter.

What percentage of the time does AEMD stock beat earnings estimates?

In the last 4 quarters, AETHLON MEDICAL INC (AEMD) has beaten EPS estimates in 2 out of 4 releases.